CSF2 and prostate carcinoma: Prostate GVAX consists of a mixture of two allogeneic, hormone-sensitive (LNCaP) and hormone-resistant (PC-3) prostate cancer cell lines, which have been lethally irradiated and genetically modified to secrete GM-CSF.